Value of18F-FES PET in Solving Clinical Dilemmas in Breast Cancer Patients: A Retrospective Study

Volume: 62, Issue: 9, Pages: 1214 - 1220
Published: May 14, 2021
Abstract
Breast cancer (BC) is a heterogeneous disease in which estrogen receptor (ER) expression plays an important role in most tumors. A clinical dilemma may arise when a metastasis biopsy to determine the ER status cannot be performed safely or when ER heterogeneity is suspected between tumor lesions. Whole-body ER imaging, such as 16α-18F-fluoro-17β-estradiol (18F-FES) PET, may have added value in these situations. However, the role of this imaging...
Paper Details
Title
Value of18F-FES PET in Solving Clinical Dilemmas in Breast Cancer Patients: A Retrospective Study
Published Date
May 14, 2021
Volume
62
Issue
9
Pages
1214 - 1220
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.